INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

ABBOTT LABORATORIES

Pharmaceutical Preparations | SIC: 2834
Phone: 2246676100

CIK: 0000001800
EIN: 360698440
State Location: IL
State of Inc.: IL

NYSE:ABT

Form: 4

Filing Date: 18 Jun 2026
Report Date: 07 May 2026
Accepted: 18 Jun 2026 03:08 p.m.
Accession Number: 0001385262-26-000017

Act: None
File Number: None
Film Number: None

Documents

Primary Document

Accepted: 18 Jun 2026 03:08 p.m.

0001385262-26-000017-index-headers.html

Last Modified: 18 Jun 2026 03:08 p.m.

0001385262-26-000017-index.html

Last Modified: 18 Jun 2026 03:08 p.m.

0001385262-26-000017.txt

Last Modified: 18 Jun 2026 03:08 p.m.

form4-06182026_090625.xml

Last Modified: 18 Jun 2026 03:08 p.m.